EconPapers    
Economics at your fingertips  
 

Ethics in public health research: Anthrax vaccine and public health policy

M.M. Weiss, P.D. Weiss and J.B. Weiss

American Journal of Public Health, 2007, vol. 97, issue 11, 1945-1951

Abstract: The Centers for Disease Control and Prevention has classified Bacillus anthracis, the causative organism of anthrax, as a category A potential bioterrorism agent. There are critical shortcomings in the US anthrax vaccine program. Rather than depending on the private sector, the government must assume direct production of anthrax vaccine. The development of a capacity capable of preemptive immunization of the public against anthrax should be considered.

Date: 2007
References: Add references at CitEc
Citations:

Downloads: (external link)
http://hdl.handle.net/10.2105/AJPH.2006.102749

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:aph:ajpbhl:10.2105/ajph.2006.102749_0

DOI: 10.2105/AJPH.2006.102749

Access Statistics for this article

American Journal of Public Health is currently edited by Alfredo Morabia

More articles in American Journal of Public Health from American Public Health Association
Bibliographic data for series maintained by Christopher F Baum ().

 
Page updated 2025-03-19
Handle: RePEc:aph:ajpbhl:10.2105/ajph.2006.102749_0